RESUMO
The ATP-dependent protease Lon (La) of Escherichia coli degrades abnormal proteins and is involved in the regulation of capsular polysaccharide synthesis. In addition, mutations in the E. coli lon gene suppress temperature-sensitive mutations in other genes. The lon gene of Borrelia burgdorferi, encoding a homolog of the Lon protease, has been cloned and sequenced. The gene encodes a protein of 806 amino acids. The deduced amino acid sequence of the B. burgdorferi Lon protease shares substantial sequence identity with those of other known Lon proteases. The transcription start point of the B. burgdorferi lon gene was identified by primer extension analysis and the potential promoter did not show similarities to the consensus heat-shock promoter in E. coli. The 5'-end of the B. burgdorferi lon gene appears to suppress the temperature-sensitive phenotype of an E. coli lpxA mutant.
Assuntos
Grupo Borrelia Burgdorferi/enzimologia , Grupo Borrelia Burgdorferi/genética , Proteínas de Escherichia coli , Proteínas de Choque Térmico/genética , Protease La , Serina Endopeptidases/genética , Proteases Dependentes de ATP , Adenosina Trifosfatases/biossíntese , Adenosina Trifosfatases/genética , Sequência de Aminoácidos , Sequência de Bases , Clonagem Molecular , Escherichia coli/enzimologia , Teste de Complementação Genética , Proteínas de Choque Térmico/biossíntese , Proteínas de Choque Térmico/química , Dados de Sequência Molecular , Filogenia , Polissacarídeos Bacterianos/biossíntese , Regiões Promotoras Genéticas , Proteínas Recombinantes/biossíntese , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Serina Endopeptidases/biossíntese , Serina Endopeptidases/química , Transcrição GênicaRESUMO
Legionella spp. are a common cause of community-acquired respiratory tract infections and an occasional cause of nosocomial pneumonia. A PCR method for the detection of legionellae in respiratory samples was evaluated and was compared to culture. The procedure can be performed in 6 to 8 h with a commercially available DNA extraction kit (Qiagen, Valencia, Calif.) and by PCR with gel detection. PCR is performed with primers previously determined to amplify a 386-bp product within the 16S rRNA gene of Legionella pneumophila. We can specifically detect the clinically significant Legionella species including L. pneumophila, L. micdadei, L. longbeachae, L. bozemanii, L. feeleii, and L. dumoffii. The assay detects 10 fg (approximately two organisms) of legionella DNA in each PCR. Of 212 clinical specimens examined by culture, 100% of the culture-positive samples (31 of 31) were positive by this assay. By gel detection of amplification products, 12 of 181 culture-negative samples were positive for Legionella species by PCR, resulting in 93% specificity. Four of the 12 samples with discrepant results (culture negative, PCR positive) were confirmed to be positive for Legionella species by sequencing of the amplicons. The legionella-specific PCR assay that is described demonstrates high sensitivity and high specificity for routine detection of legionellae in respiratory samples.
Assuntos
Legionella pneumophila/isolamento & purificação , Legionella/isolamento & purificação , Legionelose/diagnóstico , Sequência de Bases , Líquido da Lavagem Broncoalveolar/microbiologia , Primers do DNA , Variação Genética , Humanos , Legionella/classificação , Legionella/genética , Legionella pneumophila/classificação , Legionella pneumophila/genética , Doença dos Legionários/diagnóstico , Pulmão/microbiologia , Dados de Sequência Molecular , Derrame Pleural/microbiologia , Reação em Cadeia da Polimerase/métodos , RNA Ribossômico 16S/genética , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Alinhamento de Sequência , Homologia de Sequência do Ácido Nucleico , Escarro/microbiologiaRESUMO
Current methods for identification of Mycobacterium spp. rely upon time-consuming phenotypic tests, mycolic acid analysis, and narrow-spectrum nucleic acid probes. Newer approaches include PCR and sequencing technologies. We evaluated the MicroSeq 500 16S ribosomal DNA (rDNA) bacterial sequencing kit (Applied Biosystems, Foster City, Calif.) for its ability to identify Mycobacterium isolates. The kit is based on PCR and sequencing of the first 500 bp of the bacterial rRNA gene. One hundred nineteen mycobacterial isolates (94 clinical isolates and 25 reference strains) were identified using traditional phenotypic methods and the MicroSeq system in conjunction with separate databases. The sequencing system gave 87% (104 of 119) concordant results when compared with traditional phenotypic methods. An independent laboratory using a separate database analyzed the sequences of the 15 discordant samples and confirmed the results. The use of 16S rDNA sequencing technology for identification of Mycobacterium spp. provides more rapid and more accurate characterization than do phenotypic methods. The MicroSeq 500 system simplifies the sequencing process but, in its present form, requires use of additional databases such as the Ribosomal Differentiation of Medical Microorganisms (RIDOM) to precisely identify subtypes of type strains and species not currently in the MicroSeq library.